Abstract:Objective:To evaluation the performance of a total of 40 clinical biochemical reagents from three domestic manufacturers and two foreign manufacturers, and evaluate their clinical application value.Methods:The Beckman AU5400 automatic biochemical analyzer was used to verify the performance of 40 kinds of commonly used clinical biochemical reagents from three domestic manufacturers of Sichuan Maccura, Ningbo Medical System, and Shanghai Fosun Long March, and two foreign imported manufacturers of Roche and Japan′s Hitachi. The analysis samples were selected from the serum of patients who underwent clinical testing in Nanjing Drum Tower Hospital hospital from December 2021 to June 2022. Refer to China′s national health industry standards, China′s national pharmaceutical industry standards, the US Clinical Laboratory Standards Institute (CLSI) for the performance evaluation standards of in vitro diagnostic reagents, and the methods recommended in the relevant regulations of China′s State Food and Drug Administration on the management of in vitro diagnostic reagents. The precision, linear range, open bottle stability, interchangeability of calibrators and accuracy from different batches of 40 reagents were evaluated and validated. Simple linear regression analysis was used for linear regression, and P<0.05 indicated that the regression was statistically significant. Results:The overall precisions of 40 reagents were fine, except for one domestic reagent with low-level intra-batch coefficient of variation ( CV) exceeding the range declared in the specification. The intra-and inter-batch CVs of the remaining reagents were all smaller than those declared in their respective specifications. The linear ranges of domestic reagents and imported ones have achieved the linear ranges declared by each manufacturer. There were no statistical differences on the measurements between the reagents from open bottle of 30 days and the corresponding new ones for 40 reagents( P>0.05). The test values of domestic reagents and imported reagents after exchange of different batches of calibrators were within the ranges declared by each manufacturer. Both domestic reagents and imported reagents have passed the accuracy verification. Conclusions:The performance index of 27 biochemical detection indicators of the three domestic manufacturers are basically consistent with those of imported reagents, meeting the requirements of clinical biochemical laboratories. However, the bottle opening stability and anti-interference performance of some detection reagents needs to be improved.

Suggestions on Reasonably Pricing Medical Lab Test Items in China

Research on the Methodology of Calculating the Value of Laboratory Diagnosis Items

Cost accounting for diagnosis items based on virtual standardized clinical chemistry laboratory

Evaluating Performance of Local Case-Mix System by International Comparison: a Case Study in Beijing, China.

The Suggestions on Consummating the Price's Measuring and Items of Medical Services

A feasibility study on the implementation of dispensing fee in China

Comparative analysis on the price of essential medicines:Based on the sample survey of primary health care institutions and pharmacies in 18 provinces

International Experiences of Medicines Insurance Payment Pricing Mechanisms and the Implications to China

International Comparison of Drug Price Level in China

Design of a Revolutionary Pricing Method of Medical Service by Disease Types in China

Study on Charging Level of Pharmaceutical Service Fee in China

Price Adjustment for Traditional Chinese Medicine Procedures: Based on a Standardized Value Parity Model.

Survey and Analysis of Status Quo and Trend of the Price for Medical Services

Willingness to Pay for Cancer Prevention Versus Treatment in China: Implications for Cost-Effectiveness Threshold.

Analysis on Direct-Cost of Intravenous Infusion in Zhejiang,Hubei,Shaanxi and Shanghai

Empirical Study on Essential Medicine Price in China

Assessment of Medical Service Pricing in China's Healthcare System: Challenges, Constraints, and Policy Recommendations

Analysis of the "regulation of Drug Price Difference (trial Implementation)" in China

Regional Price Differences of Medical Services: Evidence from China

Preliminary exploration of medical service price reform based on choice behavior motivation

Performance evaluation of some domestically produced biochemical reagents